The application of molecular biological techniques has revealed the ex
istence of gene products encoding several novel putative receptors for
the neurotransmitter 5-hydroxytryptamine (5-HT). For most of these no
vel receptors, no prior pharmacological or functional data existed, an
d the present challenges to pharmacologists are to identify tools to s
tudy these gene products, to determine. Whether or not they function a
s endogenous receptors and to determine potential therapeutic uses of
ligands for these receptors. Here, we review work detailing the clonin
g and characterisation of the 5-HT6 receptor, its distribution and evi
dence for functional responses mediated by naturally-occurring 5-HT6 r
eceptors.